جینیاتی انجینئرنگ اور کرسپر ٹیکنالوجی کے سماجی، قانونی اور اخلاقی چیلنجز پر اسلامی نقطہ نظر
Islamic Perspectives on Social, Legal, and Ethicla Challenges of Genetic Engineering and CRISPR Technology
Keywords:
CRISPR Technology, Genetic engineering, Islamic perspectives, Modified genome, Germs Line CellsAbstract
Abstract:
The rapid developments in medical science including genetic engineering and CRISPR technology bring opportunities as well as challenges pertaining to legal, social, and ethical frameworks. This paper is aimed at exploration of the implications of the usage of these new technologies in the light of Quranic verses, prophetic traditions and principles of Islamic jurisprudence. Genetic modification in humans, animals, and plants has raised concerns due to legal, social, ethical consequences such as manipulation and issues related to equity, access to technology, and potential societal divisions based on genetic privilege. This study addresses these concerns considering Islamic principles such as the sanctity of life, the concept of nature and the responsibilities of stewardship (Khilafah) over creation.
The method used in this study is qualitative. This research suggests that to better address the complex ethical, legal, and societal challenges in the field of CRISPR gene editing a collaborative strategy should be adopted by scholars, scientists, policy makers, and stakeholders of relevant authorities. A holistic, pragmatic, and comprehensive approach based on foundational principles of Islam can help us reap the benefits CRISPR technology and navigate the unavoidable challenges appropriately.
Keywords:
CRISPR Technology, Genetic engineering, Islamic perspectives, Modified genome, Germs Line Cells
Additional Files
Published
Issue
Section
License
Copyright (c) 2024 Majallah-e-Talim o Tahqiq

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.